| 2000 |
A G→A substitution mutation in a splice acceptor site within Rabggta (encoding the alpha-subunit of Rab geranylgeranyl transferase, RabGGTase/GGTase II) in the gunmetal mouse causes skipping of exon 1 and loss of start codon, reducing Rabggta protein and RabGGTase activity ~4-fold in platelets; this leads to significantly decreased geranylgeranylation and membrane association of Rab27, resulting in thrombocytopenia, prolonged bleeding, and reduced platelet granule contents. |
Positional cloning, splice-site mutation characterization, biochemical measurement of GGTase activity in platelets, and geranylgeranylation/membrane-association assay of Rab27 in mutant vs. wild-type platelets |
Proceedings of the National Academy of Sciences of the United States of America |
High |
10737774
|
| 1997 |
The human RABGGTA gene (encoding the alpha-subunit of Rab geranylgeranyl transferase) is positioned in a tandem head-to-tail arrangement with the TGM1 gene, with the RABGGTA polyadenylation signal located only 2.3 kbp upstream of the TGM1 cap site; however, RT-PCR analysis under multiple differentiation conditions showed that RABGGTA expression in epidermal keratinocytes is unaffected by calcium concentration, retinoic acid, vitamin D3, or TPA, while TGM1 expression is strongly affected by these same stimuli—demonstrating the two genes are not functionally co-regulated despite close physical linkage. |
RT-PCR of RABGGTA and TGM1 expression in normal human epidermal keratinocytes under various differentiation conditions; genomic structure characterization |
Biochemical and biophysical research communications |
Medium |
9196026
|
| 2000 |
The 5'-UTR structure of the human RABGGTA gene shares organizational features with the mouse Rabggta gene (exon alpha upstream of intron alpha), and features of the 5'-UTR are consistent with a housekeeping gene; sequencing of the entire coding region in patients with platelet storage pool deficiencies (alpha-SPD, delta-SPD, gray platelet syndrome) identified several polymorphisms but no obvious disease-causing mutations, indicating these patients do not have RABGGTA coding mutations. |
Sequencing of complete coding region and 5'-UTR of RABGGTA in patients with platelet storage pool deficiencies and normal individuals; comparative genomic analysis |
Molecular genetics and metabolism |
Medium |
11136552
|
| 2016 |
Knockdown of RABGGTA (encoding a subunit of RabGGTase/GGTase II) in human cancer cell lines induces an anti-proliferative effect similar to zoledronic acid, and this effect is rescued by geranylgeranyl diphosphate (GGPP) supplementation, demonstrating that RABGGTA-mediated geranylgeranylation of Rab proteins mediates the anti-cancer mechanism of zoledronic acid. |
siRNA knockdown of RABGGTA in cancer cell lines (GBM, breast cancer); cell proliferation assay; GGPP rescue experiment |
Oncotarget |
Medium |
27462771
|
| 2022 |
AAV8-mediated knockdown of liver RABGGTA (the alpha-subunit of GGTase II) in vivo causes systemic glucose metabolism disorders; pharmacological and genetic inhibition of GGTase II disrupts hepatic insulin signaling by blocking geranylgeranylation of RAB14, which inhibits AKT (Ser473) phosphorylation and impairs mTORC2 complex assembly; GGPP supplementation rescues the defect. |
AAV8-mediated in vivo liver-specific Rabggta knockdown; siRNA screening to identify RAB14; geranylgeranylation assay; AKT phosphorylation assay; mTORC2 assembly assay; GGPP rescue in vitro and in vivo |
Metabolism: clinical and experimental |
High |
34995578
|
| 2022 |
AAV9-mediated knockdown of RABGGTA in skeletal muscle impairs glucose disposal in vivo without disrupting insulin signaling (AKT phosphorylation unaffected); geranylgeranylation deficiency of RAB8A (a GGTase II substrate) specifically inhibits insulin-stimulated GLUT4 translocation and glucose uptake in skeletal muscle cells, identifying RAB8A as the relevant Rab substrate downstream of RABGGTA in this tissue. |
AAV9-mediated in vivo skeletal muscle RABGGTA knockdown; glucose uptake assay; RAB8A geranylgeranylation-site mutation; GLUT4 translocation assay; AKT phosphorylation assay |
Journal of cachexia, sarcopenia and muscle |
High |
35961942
|
| 2025 |
In vivo CRISPR screening using CrAAVe-seq in mouse neurons validated Rabggta as an essential gene for neuronal survival; sgRNA-mediated depletion of Rabggta led to loss of neurons, establishing a required role for Rab geranylgeranylation in neuronal viability. |
In vivo pooled CRISPR screening (CrAAVe-seq) with AAV-delivered sgRNA libraries in mouse brains; validated by neuronal survival assay |
Nature neuroscience |
Medium |
40847019
|